A photo of Angela Lorts.

Director, Ventricular Assist Device Program

Associate Chief Quality Officer – Outcomes

Professor, UC Department of Pediatrics



Board Certified

Best Doctors logo

My Biography & Research

Clinical Interests

Advanced heart failure; cardiopulmonary bypass mediated myocardial dysfunction; novel uses of pediatric VADs; cardiomyopathy; mechanical circulatory support and transplant

Research Interests

Myocardial remodeling

Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Cardiomyopathy, Heart Failure, Heart, Cardio-Oncology, Fontan Management

Research Divisions


Blog Posts

Heart Assist Devices Making a Difference

Heart and Lung

Heart Assist Devices Making a Difference

Angela Lorts, MD, MBA, David L. S. Morales, MD ...6/30/2019

My Education

MD: Creighton University Medical School, Omaha, NE, 1998.

Residency: The Children’s Hospital, Denver, CO, 2001.

Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2004; University of Michigan Medical Center, Ann Arbor, MI, 2006.

Certifications: American Board of Pediatrics, 2001; American Board of Pediatrics, Sub-Board of Pediatric Cardiology, 2004; American Board of Pediatrics, Sub-Board of Pediatric Critical Care, 2006.

My Publications

Selected Publication

Utilization and Outcomes of Children Treated with Direct Thrombin Inhibitors on Paracorporeal Ventricular Assist Device Support. VanderPluym, CJ; Cantor, RS; Machado, D; Boyle, G; May, L; Griffiths, E; Niebler, RA; Lorts, A; Rossano, J; Sutcliffe, DL; et al. ASAIO Journal. 2020; 66:939-945.

Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis. O'Connor, MJ; Lorts, A; Davies, RR; Fynn-Thompson, F; Joong, A; Maeda, K; Mascio, CE; McConnell, PI; Monge, MC; Nandi, D; et al. Journal of Heart and Lung Transplantation. 2020; 39:573-579.

The Creation of a Pediatric Health Care Learning Network: The ACTION Quality Improvement Collaborative. Lorts, A; Smyth, L; Gajarski, RJ; VanderPluym, CJ; Mehegan, M; Villa, CR; Murray, JM; Niebler, RA; Almond, CS; Thrush, P; et al. ASAIO Journal. 2020; 66:441-446.

Cost-utility of continuous-flow ventricular assist devices as bridge to transplant in pediatrics. Evers, PD; Villa, C; Wittekind, SG; Hobing, R; Morales, DL S; Lorts, A. Pediatric Transplantation. 2019; 23.

Collaboration and new data in ACTION: a learning health care system to improve pediatric heart failure and ventricular assist device outcomes. Peng, DM; Rosenthal, DN; Zafar, F; Smyth, L; VanderPluym, CJ; Lorts, A. Translational pediatrics. 2019; 8:349-355.

Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: Preimplant Characteristics and Outcomes. Morales, DL S; Rossano, JW; VanderPluym, C; Lorts, A; Cantor, R; St Louis, JD; Koeh, D; Sutcliffe, DL; Adachi, I; Kirklin, JK; et al. Annals of Thoracic Surgery. 2019; 107:993-1004.

Outcomes of children supported with an intracorporeal continuous-flow left ventricular assist system. VanderPluym, CJ; Adachi, I; Niebler, R; Griffiths, E; Fynn-Thompson, F; Chen, S; O'Connor, MJ; Machado, D; Hawkins, B; Bleiweis, MS; et al. Journal of Heart and Lung Transplantation. 2019; 38:385-393.

First Use of HeartMate 3 in a Failing Fontan Circulation. Lorts, A; Villa, C; Riggs, KW; Broderick, J; Morales, DL S. Annals of Thoracic Surgery. 2018; 106:e233-e234.

Mechanical circulatory support challenges in pediatric and (adult) congenital heart disease. Schweiger, M; Lorts, A; Conway, J. Current Opinion in Organ Transplantation. 2018; 23:301-307.

Utilization of VADs in children with restrictive and hypertrophic cardiomyopathy: Are we there yet?. Villa, C; Broderick, J; Rizwan, R; Lorts, A. Progress in Pediatric Cardiology. 2018; 49:47-49.